Real-World Evidence Data on Metastatic Renal-Cell Carcinoma Treatment in Austria: The RELACS Study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Real-World Evidence Data on Metastatic Renal-Cell Carcinoma Treatment in Austria: The RELACS Study

Published:2019-10 Issue:5 Volume:17 Page:e957-e967
ISSN:1558-7673
Container-title:Clinical Genitourinary Cancer
language:en
Short-container-title:Clinical Genitourinary Cancer

Author:

Schmidinger Manuela,Pichler Renate,Loidl Wolfgang,Bauernhofer Thomas,Kretz Matthias,Tinchon Christoph,Niedersüß-Beke Dora,Pfleger Gottfried,Wiesinger Clemens Georg,Vogl Ursula,Mitterberger Michael,Stöger Herbert,Tulchiner Gennadi,Kratochvill Franz,Gerritsmann Hanno,Mraz Bernhard,Marszalek Martin

Funder

Roche

Pfizer

BMS

Ipsen

Janssen

Olympus

Medtronic

Astellas Pharma

Baxter

Fondazione Internationale Menarini

Novartis Pharma GmbH

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference16 articles.

1. Cancer statistics, 2017;Siegel;CA Cancer J Clin,2017

2. New treatment options for metastatic renal cell carcinoma;Rodriguez-Vida;ESMO Open,2017

3. Cabozantinib versus sunitinib as initial therapy for metastatic renal cell carcinoma of intermediate or poor risk (Alliance A031203 CABOSUN randomised trial): progression-free survival by independent review and overall survival update;Choueiri;Eur J Cancer,2018

4. Nivolumab plus ipilimumab versus sunitinib in advanced renal-cell carcinoma;Motzer;N Engl J Med,2018

5. Swarm-based medicine;Putora;J Med Internet Res,2013

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-World Treatment Patterns and Effectiveness of Patients With Advanced Renal Cell Carcinoma: A Nationwide Observational Study;Clinical Genitourinary Cancer;2023-11

2. Renal cell carcinoma management: real-world practice and challenges at a national level;Future Oncology;2023-04

3. Long-Term Response to Tyrosine Kinase Inhibitors for Metastatic Renal Cell Carcinoma;Biomedicines;2022-09-30

4. Real World Overall Survival of Patients With Metastatic Renal Cell Carcinoma Treated With Only Available Sunitinib and Pazopanib in First-Line Setting;Frontiers in Oncology;2022-06-08

5. Real-World Metastatic Renal Cell Carcinoma Treatment Patterns and Clinical Outcomes in The Netherlands;Frontiers in Pharmacology;2022-03-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3